Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoChange DetectedThe page has added a section with helpful links provided by Pfizer, which includes information on how to obtain contact details for a study center nearby.SummaryDifference0.8%
- Check23 days agoChange DetectedThe page has been updated to reflect a new version of the study, now labeled as revision v2.15.0, and includes the study's focus on Sickle Cell Disease and its double-blind nature. However, significant details regarding the study's design, inclusion and exclusion criteria, and specific identifiers have been removed.SummaryDifference14%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe webpage has removed a notice regarding heavy traffic affecting NLM-NCBI services and a link to obtain contact information for a study center provided by Pfizer.SummaryDifference2%
Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.